Cholesterol-rich feeding supplies the metabolic stimulus for lipid accumulation in the arterial wall, while vascular injury can provide an additional local trigger. Together, these conditions promote endothelial dysfunction, inflammation, and plaque development. The model therefore allows investigators to examine how systemic dietary exposure and arterial damage contribute to progressively altered vessel pathology.
Plaque formation can be followed as a connected pathological sequence rather than as isolated events. Lipid accumulation occurs in the arterial wall alongside endothelial dysfunction and inflammation, and these changes support subsequent plaque development. Examining the sequence helps researchers relate visible lesions to underlying vascular biology, which is important when interpreting pathology or testing interventions.
Unlike a purely cellular experiment, this in vivo system preserves interactions within an intact arterial environment. It links vascular pathology to responses produced in a whole animal, creating a bridge between cell-based findings and human cardiovascular disease. That context is particularly useful when investigators need to assess plaque behavior, imaging, or therapeutic effects beyond isolated cells.
The rabbit model is useful partly because its anatomy is relatively accessible and its responses can be measured. These features support direct study of arterial plaques, vascular pathology, and changes associated with experimental treatment. Measurable outcomes also make it practical for comparing lesion formation or plaque-related effects across research conditions.
An experimental workflow commonly begins with cholesterol-rich feeding to promote vascular changes. Some designs pair that diet with vascular injury, after which researchers examine arterial plaque development and related pathology. This approach can be aligned with studies of plaque biology, vascular mechanisms, imaging methods, or responses to a candidate intervention, depending on the research question.
Because arterial plaques and vascular pathology can be examined in an intact animal, the model provides a setting for evaluating imaging methods in relation to lesion development. Imaging can be interpreted alongside measurable vascular responses and plaque biology, helping researchers connect what a technique detects with the underlying experimental disease process.
Investigators can use the system to test interventions intended to reduce lesion formation or influence plaque instability. Observing treatment-associated changes in arterial pathology and measurable responses provides preclinical evidence about whether a candidate approach affects disease-related processes. The model thus connects mechanistic investigation with early evaluation of cardiovascular therapies.